Log in to save to my catalogue

Pyrazoline derivatives as promising novel antischistosomal agents

Pyrazoline derivatives as promising novel antischistosomal agents

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c796c9cec571489f881af2f237580804

Pyrazoline derivatives as promising novel antischistosomal agents

About this item

Full title

Pyrazoline derivatives as promising novel antischistosomal agents

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-12, Vol.11 (1), p.23437-23437, Article 23437

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Praziquantel is the only available drug to treat schistosomiasis, a parasitic disease that currently infects more than 240 million people globally. Due to increasing concerns about resistance and inadequate efficacy there is a need for new therapeutics. In this study, a series of 17 pyrazolines (
15–31
) and three pyrazoles (
32–34
) we...

Alternative Titles

Full title

Pyrazoline derivatives as promising novel antischistosomal agents

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c796c9cec571489f881af2f237580804

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c796c9cec571489f881af2f237580804

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-02792-0

How to access this item